Keryx Biopharmaceuticals buy stratec
Start price
08.11.17
/
50%
€4.62
Target price
08.11.18
€7.22
Performance (%)
-41.60%
End price
08.11.18
€2.70
Summary
This prediction ended on 08.11.18 with a price of €2.70. The BUY prediction by stratec for Keryx Biopharmaceuticals performed very badly with a performance of -41.60%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Keryx Biopharmaceuticals | - | - | - | - |
| iShares Core DAX® | -2.526% | -5.194% | 4.911% | 51.996% |
| iShares Nasdaq 100 | -0.032% | 1.561% | 21.789% | 95.664% |
| iShares Nikkei 225® | -4.202% | -7.550% | 31.128% | 52.994% |
| iShares S&P 500 | -0.802% | 0.160% | 15.782% | 66.529% |
Comments by stratec for this prediction
In the thread Keryx Biopharmaceuticals diskutieren
stratec stimmt der Buy-Einschätzung von klostergang zu
stratec stimmt am 08.11.2017 der Buy-Einschätzung von klostergang mit dem Kursziel 8$ zu.Überschrift: klostergang stimmt der fundamentalen Bewertung mit dem Ergebnis 'unterbewertet' zu
(Laufzeit überschritten)